Cancer Family
Embryonal Neoplasm
CI-CAN-00000013Explore in graph →
Loading cancer entity…
Cancer Family
CI-CAN-00000013Explore in graph →
Variants & evidence
172 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| CTNNB1 Exon 3 Deletion1 | ||||||||
| (diagnostic) | Hepatoblastoma | Diagnostic | B | Supports Positive | 2 | submitted | EID9662Characterization of hepatoblastoma (HB) with whole-exome sequencing identified recurrent CTNNB1 mutations in 12 of 15 tumors. All 12 impacted exon 3, including 4 missense mutations at position G34 (G3… (full text at CIViC) PMID 25135868 · Eichenmüller et al., 2014 · Open in CIViC | civic |
| CTNNB1 Exon 3 Mutation6 | ||||||||
| (prognostic) | MedulloblastomaCURATED_BROADER | Prognostic | B | Supports Better Outcome | 4 | submitted | EID7966In a study of 109 pediatric medulloblastomas, children with medulloblastomas that showed a nucleopositive beta-catenin immunophenotype (27 of 109; 25%) had significantly better overall (OS) and event-… (full text at CIViC) PMID 16258095 · Ellison et al., 2005 · Open in CIViC | civic |
| (diagnostic) | Childhood Medulloblastoma | Diagnostic | B | Supports Positive | 4 | accepted | EID7967A total of 51 medulloblastomas from two independent cohorts (19 and 32 cases) were assessed for evidence of Wnt/Wg pathway activation, alongside a genome-wide analysis of associated copy-number aberra… (full text at CIViC) PMID 17172831 · Clifford et al., 2006 · Open in CIViC | civic |
| (prognostic) | Childhood Medulloblastoma | Prognostic | B | Supports | ||||
| CTNNB1 G34E1 | ||||||||
| (diagnostic) | Hepatoblastoma | Diagnostic | B | Supports Positive | 1 | submitted | EID9665Characterization of hepatoblastoma (HB) with whole-exome sequencing identified recurrent CTNNB1 mutations in 12 of 15 tumors. All 12 impacted exon 3, including 4 missense mutations at position G34 (G3… (full text at CIViC) PMID 25135868 · Eichenmüller et al., 2014 · Open in CIViC | civic |
| CTNNB1 G34R1 | ||||||||
| (prognostic) | Childhood Medulloblastoma | Prognostic | C | Supports Better Outcome | 3 | submitted | EID9014A retrospective study evaluated 72 pediatric medulloblastoma patients for CTNNB1 mutations (by direct sequencing), copy number alterations (by array-comparative genomic hybridization), and beta-cateni… (full text at CIViC) PMID 19197950 · Fattet et al., 2009 · Open in CIViC | civic |
| CTNNB1 G34V2 | ||||||||
| (diagnostic) | Hepatoblastoma | Diagnostic | B | Supports Positive | 2 | submitted | EID9664Characterization of hepatoblastoma (HB) with whole-exome sequencing identified recurrent CTNNB1 mutations in 12 of 15 tumors. All 12 impacted exon 3, including 4 missense mutations at position G34 (G3… (full text at CIViC) PMID 25135868 · Eichenmüller et al., 2014 · Open in CIViC | civic |
| 〃 | Hepatoblastoma | Diagnostic | E | Supports Positive | 2 | submitted | EID6973Five mutations resulted in amino acid substitutions in codons 32 and 34, suggesting an influence on the accessibility of the serine 33 for the GSK-3β kinase, preventing its phosphorylation (Fig. 2a) PMID 9927029 · Koch et al., 1999 · Open in CIViC | civic |
| CTNNB1 I35K1 | ||||||||
| (prognostic) | Childhood Medulloblastoma | Prognostic | C | Supports Better Outcome | 3 | submitted | EID9016A retrospective study evaluated 72 pediatric medulloblastoma patients for CTNNB1 mutations (by direct sequencing), copy number alterations (by array-comparative genomic hybridization), and beta-cateni… (full text at CIViC) PMID 19197950 · Fattet et al., 2009 · Open in CIViC | civic |
| CTNNB1 S33F1 | ||||||||
| (prognostic) | Childhood Medulloblastoma | Prognostic | C | Supports Better Outcome | 4 | submitted | EID9015A retrospective study evaluated 72 pediatric medulloblastoma patients for CTNNB1 mutations (by direct sequencing), copy number alterations (by array-comparative genomic hybridization), and beta-cateni… (full text at CIViC) PMID 19197950 · Fattet et al., 2009 · Open in CIViC | civic |
| CTNNB1 S37C1 | ||||||||
| Unspecified therapy | Hepatoblastoma | Predictive | E | Supports Sensitivity Response | 3 | submitted | EID6089The evidence from the literature describes the association of CTNNB1 mutation to Hepatoblastoma (HB) via detecting CTNNB1 mutation in HB cell lines through molecular techniques. In conclusion, 78% (21… (full text at CIViC) PMID 12101426 · Taniguchi et al., 2002 · Open in CIViC | civic |
| CTNNB1 S45F5 | ||||||||
| (diagnostic) | Wilms TumorCURATED_BROADER | Diagnostic | B | Supports N/A | 5 | rejected | EID6086153 primary Wilms tumor samples from 150 patients were analyzed for mutations in the WT1 and CTNNB1 genes. Ten WT samples had the S45F, and 9 of them also had WT1 mutation. This study concluded a high… (full text at CIViC) PMID 11103785 · Maiti et al., 2000 · Open in CIViC | civic |
| 〃 | Wilms TumorCURATED_BROADER | Diagnostic | B | Supports N/A | 4 | rejected | EID6084This study analysed all five loci (WT1, CTNNB1, WTX, TP53 and the imprinted 11p15 region) in 120 Wilms tumors, and identify CTNNB1 mutation in 15% samples. Data on the 5 loci stratify Wilms tumors int… (full text at CIViC) PMID 22470196 · Scott et al., 2012 · Open in CIViC | civic |
| 〃 | Wilms TumorCURATED_BROADER | |||||||
| CTNNB1 T41A1 | ||||||||
| Unspecified therapy | Hepatoblastoma | Predictive | B | Supports Sensitivity Response | 4 | submitted | EID6078Of 39 hepatoblastoma samples, 10 tumor samples had point mutations in exon 3 of beta-catenin gene. One mutation changes threonine at position 41 to alanine (T41A). PMID 16937357 · Sugawara et al., 2007 · Open in CIViC | civic |
| DICER1 D1810Y1 | ||||||||
| (oncogenic) | Pleuropulmonary Blastoma | Oncogenic | D | Supports Oncogenicity | 2 | submitted | EID6093Sanger sequencing of several pleuropulmonary blastoma tumor lines showed possible somatic missense mutation, D1810Y, in DicerI. All mutations thought to be somatic were found in the RNase IIIb domain.… (full text at CIViC) PMID 24675358 · Seki et al., 2014 · Open in CIViC | civic |
| DICER1 E1813D + DICER1 R392fs1 | ||||||||
| (oncogenic) | Pleuropulmonary Blastoma | Oncogenic | C | Supports Oncogenicity | 1 | submitted | EID7059These two mutations were identified in the tumor tissue in an NGS based panel and were not seen in the adjacent normal lung tissue. This confirms it as a rare case of somatically acquired Biallelic mu… (full text at CIViC) PMID 24909177 · Pugh et al., 2014 · Open in CIViC | civic |
| DICER1 Loss-of-function + DICER1 RNase IIIb Mutation2 | ||||||||
| (diagnostic) | Pituitary Gland BlastomaALIAS | Diagnostic | B | Supports Positive | 3 | submitted | EID11482An analysis of 13 infants with pituitary blastoma (age 7-24 months) demonstrated recurrent DICER1 mutations. Of those with samples available for sequencing, 9 of 9 (100%) had germline DICER1 mutation… (full text at CIViC) PMID 24839956 · de Kock et al., 2014 · Open in CIViC | civic |
| 〃 | Pituitary Gland BlastomaALIAS | Diagnostic | B | Supports Positive | 2 | submitted | EID11483This 2021 paper analyzed the outcomes and complications of 17 patients with pituitary blastoma. The median age of diagnosis was 11 months with a range of 2-24 months. Germline DICER1 variants were… (full text at CIViC) PMID 33236116 · Liu et al., 2021 · Open in CIViC | civic |
| DROSHA E518K1 | ||||||||
| (prognostic) | Kidney Wilms TumorALIAS | Prognostic | B | Supports Poor Outcome | 4 | submitted | EID6090A higher relapse rate was observed in patients that have both DROSHA E518K and SIX Q177R muations. PMID 25670082 · Walz et al., 2015 · Open in CIViC | civic |
| EGFR Expression1 | ||||||||
| Lapatinib | Chordoma | Predictive | B | Supports Sensitivity Response | 2 | accepted | EID198418 advanced progressing chordoma patients that were positive for EGFR by at least one technique (immunohistochemistry and/or phospho-arrays, real-time polymerase chain reaction for EGFR ligands, FISH)… (full text at CIViC) PMID 23559153 · Stacchiotti et al., 2013 · Open in CIViC | civic |
| EGFR ITD1 | ||||||||
| (diagnostic) | Congenital Mesoblastic Nephroma | Diagnostic | B | Supports Positive | 3 | submitted | EID11281In an analysis of 22 cases of mesoblastic nephroma, 4 of 5 (80%) cellular mesoblastic nephromas harbored ETV6::NTRK3, 1 of 5 cellular mesoblastic nephromas harbored a KLHL7::BRAF fusion, 12 of 12 (100… (full text at CIViC) PMID 32590884 · Zhao et al., 2020 · Open in CIViC | civic |
| NTRK3 Fusion1 | ||||||||
| (diagnostic) | Congenital Mesoblastic Nephroma | Diagnostic | C | Supports Positive | 3 | accepted | EID10420To determine if EML4::NTRK3 fusions were recurrent in tumors known to harbor ETV6::NTRK3 fusions, the authors screened 63 cases with varying diagnoses (infantile fibrosarcoma, congenital mesoblastic n… (full text at CIViC) PMID 29099503 · Church et al., 2018 · Open in CIViC | civic |
| ETV6 ~DEPRECATED-ETV6::NTRK3 FUSION1 | ||||||||
| (diagnostic) | Congenital Mesoblastic Nephroma | Diagnostic | C | Supports Positive | 2 | rejected | EID10417EML6::NTRK3 fusion is seen in cases of Infantile fibrosarcoma and congenital mesoblastic nephroma. In general, these types of tumors more commonly harbor ETV6::NTRK3 fusions. PMID 29099503 · Church et al., 2018 · Open in CIViC | civic |
| NTRK3 Fusion5 | ||||||||
| (diagnostic) | Congenital Mesoblastic Nephroma | Diagnostic | B | Supports Positive | 3 | accepted | EID10841A frequent genetic alteration in congenital mesoblastic nephroma is the translocation t(12;15) resulting in a fusion of the ETV6 gene on 12p13 and the NTRK3 gene on 15p15 that occurs almost exclusivel… (full text at CIViC) PMID 29286563 · Vokuhl et al., 2018 · Open in CIViC | civic |
| (prognostic) | Congenital Mesoblastic Nephroma | Prognostic | B | Supports Better Outcome | 3 | submitted | EID10842In a group of 111 mesoblastic nephroma (MN) samples, 79 were were evaluable by FISH, which consisted of 38 classical MN, 29 cellular MN, and 12 mixed MN samples. 5 year relapse free survival (RFS) was… (full text at CIViC) PMID 29286563 · Vokuhl et al., 2018 · Open in CIViC | civic |
| (diagnostic) | Congenital Mesoblastic Nephroma | Diagnostic | B | Supports Positive | 3 | |||
| ERG Fusion3 | ||||||||
| (diagnostic) | Ewing Sarcoma | Diagnostic | B | Supports Positive | 5 | accepted | EID475The t(21;22) rearrangement resulting in the EWSR1::ERG fusion is associated with the diagnosis of Ewing sarcoma. EWSR1::ERG is the second most common gene fusion reported in this disease. PMID 23706910 · Warren et al., 2013 · Open in CIViC | civic |
| 〃 | Ewing Sarcoma | Diagnostic | C | Supports Positive | 3 | accepted | EID10338Molecular analysis of 30 Ewing tumors (designated as Ewing's sarcomas and primitive neuroectodermal tumors (PNET) in this 1994 paper) from patients with well-documented clinical course was performed. … (full text at CIViC) PMID 7524604 · Zoubek et al., 1994 · Open in CIViC | civic |
| 〃 | Ewing Sarcoma | Diagnostic | C | Supports Positive | 2 | accepted | EID11603An analysis of 85 small blue round cell tumors (SBRCTs) that were negative for EWSR1, CIC, or BCOR by FISH identified 6 FUS::ERG and 1 FUS::FEV fusions. Clinicopathologic characterization of these 7 … | |
| FLI1 e7::e61 | ||||||||
| (prognostic) | Ewing Sarcoma | Prognostic | B | Supports Better Outcome | 4 | accepted | EID431In patients with Ewing's sarcoma, those with type 1 EWS-FLI1 fusions had longer overall survival than those with other types of EWS-FLI1 fusions. PMID 9552022 · de Alava et al., 1998 · Open in CIViC | civic |
| FLI1 Fusion7 | ||||||||
| (diagnostic) | Ewing Sarcoma | Diagnostic | B | Supports Positive | 5 | accepted | EID478t(11;22) rearrangements of EWSR1-FLI1 are diagnostic of ewing sarcoma, and are observed in 90% of cytogenetic samples. PMID 23706910 · Warren et al., 2013 · Open in CIViC | civic |
| 〃 | Bone Ewing SarcomaALIAS | Diagnostic | B | Supports Positive | 4 | accepted | EID1752A total of 85 unrelated cases of Ewing's sarcoma were examined and 83% were found to harbor the t(11;22)(q24;q12) chromosomal abnormality knwon to result in the EWSR1::FLI1 fusion. PMID 3163261 · Turc-Carel et al., 1988 · Open in CIViC | civic |
| 〃 | Bone Ewing SarcomaALIAS | Diagnostic | B | Supports Positive | 3 | accepted | ||
| EZH2 Overexpression1 | ||||||||
| GSK126 + TazemetostatSequential | Neuroblastoma | Predictive | D | Supports Sensitivity Response | 2 | submitted | EID9115Within this preclinical study, 87 patients with neuroblastoma and 14 neuroblastoma cell lines were evaluated for overexpression of EZH2 and possible prognostic factors. In patient samples the average … (full text at CIViC) PMID 28214660 · Bate-Eya et al., 2017 · Open in CIViC | civic |
| FGFR1 Amplification1 | ||||||||
| Ponatinib | Bone Ewing SarcomaALIAS | Predictive | D | Supports Sensitivity Response | 3 | accepted | EID1247116 Ewing's sarcoma tumor samples were analyzed in this study. 2 patient's samples underwent whole genome sequencing, tumor samples from 51 patients underwent exome sequencing and expression analysis,… (full text at CIViC) PMID 26179511 · Agelopoulos et al., 2015 · Open in CIViC | civic |
| FGFR1 N546K1 | ||||||||
| Ponatinib | Bone Ewing SarcomaALIAS | Predictive | E | Supports Sensitivity Response | 2 | accepted | EID1246116 Ewing's sarcoma tumor samples were analyzed in this study. 2 patient's samples underwent whole genome sequencing, tumor samples from 51 patients underwent exome sequencing and expression analysis,… (full text at CIViC) PMID 26179511 · Agelopoulos et al., 2015 · Open in CIViC | civic |
| FGFR1 Overexpression1 | ||||||||
| (oncogenic) | Neuroblastoma | Oncogenic | D | Supports Oncogenicity | 5 | submitted | EID11022In neuroblastoma, high FGFR1 expression is associated with metastatic and relapsed tumors and inferior relapse-free survival, suggesting its role in promoting disease progression and recurrence. In vi… (full text at CIViC) PMID 35488346 · Cimmino et al., 2022 · Open in CIViC | civic |
| FGFR3 Amplification1 | ||||||||
| Pazopanib | Ewing Sarcoma | Predictive | C | Supports Sensitivity Response | 2 | submitted | EID7835Clinical trial of soft tissue sarcoma patients found no responses to pazopanib + trametinib combination in Ewing sarcoma patients. Comparison was done to previously treated Ewing sarcoma that responde… (full text at CIViC) PMID 28377484 · Subbiah et al., 2017 · Open in CIViC | civic |
Data updated 16 hours agoSource updated unknownsource: civic (CC0)
Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.
| 4 |
| submitted |
EID9013This retrospective study evaluated 72 pediatric medulloblastoma patients for CTNNB1 mutations (by direct sequencing), copy number alterations (by array-comparative genomic hybridization), and beta-cat… (full text at CIViC) PMID 19197950 · Fattet et al., 2009 · Open in CIViC |
| civic |
| (diagnostic) | Hepatoblastoma | Diagnostic | B | Supports Positive | 3 | submitted | EID7922The authors analyzed 52 hepatoblastoma (HB) biopsies and three HB cell lines from sporadic HBs and found 48% of them bearing mutations on beta-catenin exon 3, which encodes the degradation targeting… (full text at CIViC) PMID 9927029 · Koch et al., 1999 · Open in CIViC | civic |
| 〃 | Childhood Medulloblastoma | Diagnostic | B | Supports Positive | 3 | accepted | EID7965A series of 72 pediatric medulloblastomas were evaluated for CTNNB1 mutations (by direct sequencing), copy number alterations (by array-comparative genomic hybridization), and beta-catenin protein exp… (full text at CIViC) PMID 19197950 · Fattet et al., 2009 · Open in CIViC | civic |
| 〃 | Hepatoblastoma | Diagnostic | B | Supports Positive | 2 | submitted | EID9663Characterization of hepatoblastoma (HB) with whole-exome sequencing identified recurrent CTNNB1 mutations in 12 of 15 tumors. All 12 impacted exon 3, including 4 missense mutations at position G34 (G3… (full text at CIViC) PMID 25135868 · Eichenmüller et al., 2014 · Open in CIViC | civic |
| B |
| Supports N/A |
| 4 |
| rejected |
EID6085Exon 3 of the CTNNB1 gene and its flanking regions encompassing mutational hot spots of the gene were examined by PCR-based methods in 24 tumors from 20 Wilms tumor (WT) patients. Six tumors (6/24, 25… (full text at CIViC) PMID 12239584 · Kusafuka et al., 2002 · Open in CIViC |
| civic |
| 〃 | Wilms TumorCURATED_BROADER | Diagnostic | B | Supports N/A | 3 | rejected | EID6083Variant found in tumors samples in two patients with pediatric Wilms’ tumor. PMID 19024596 · Su et al., 2008 · Open in CIViC | civic |
| 〃 | Wilms TumorCURATED_BROADER | Diagnostic | C | Supports N/A | 2 | rejected | EID6082One patient with a novel WT1 pS50X germ line mutation who developed bilateral Wilms tumors. One of the 4 independent tumor sites showed LOH of the wild type WT1 allele, and S45F in the CTNNB1 gene. PMID 17551084 · Uschkereit et al., 2007 · Open in CIViC | civic |
| accepted |
EID11279In an analysis of 19 cases of mesoblastic nephroma, the ETV6::NTRK3 fusion was detected in 0 of 5 of the classic mesoblastic nephroma, 8 of 8 (100%) of the cellular mesoblastic nephroma and 5 of 6 (83… (full text at CIViC) PMID 27020209 · El Demellawy et al., 2016 · Open in CIViC |
| civic |
| 〃 | Congenital Mesoblastic Nephroma | Diagnostic | B | Supports Positive | 2 | accepted | EID11280In an analysis of 22 cases of mesoblastic nephroma, 4 of 5 (80%) cellular mesoblastic nephromas harbored ETV6::NTRK3, 1 of 5 cellular mesoblastic nephromas harbored a KLHL7::BRAF fusion, 12 of 12 (100… (full text at CIViC) PMID 32590884 · Zhao et al., 2020 · Open in CIViC | civic |
| Larotrectinib | Congenital Mesoblastic Nephroma | Predictive | C | Supports Sensitivity Response | 4 | accepted | EID10840A 23 month old (at the time of report) male was diagnosed prenatally with Stage II cellular mesoblastic nephroma (MN) on the right kidney, which was surgically removed on the sixth day of life. ETV6::… (full text at CIViC) PMID 29893456 · Halalsheh et al., 2018 · Open in CIViC | civic |
PMID 26690869 · Chen et al., 2016 · Open in CIViC
| civic |
EID1754An evaluation of alternative strategies for detection of EWS-FLI (FISH break apart, FISH fusion, and RT-PCR). Of the 22 informative EWS/PNETs, 20 cases (91%) were positive by FISH break apart, FISH f… (full text at CIViC) PMID 16258512 · Bridge et al., 2006 · Open in CIViC |
| civic |
| 〃 | Ewing Sarcoma | Diagnostic | B | Supports Positive | 3 | accepted | EID10337Molecular analysis of 30 Ewing tumors (designated as Ewing's sarcomas and primitive neuroectodermal tumors (PNET) in this 1994 paper) from patients with well-documented clinical course was performed. … (full text at CIViC) PMID 7524604 · Zoubek et al., 1994 · Open in CIViC | civic |
| 〃 | Bone Ewing SarcomaALIAS | Diagnostic | B | Supports Positive | 2 | accepted | EID1753The authors propose RT-PCR as a diagnostic test for Ewing sarcoma using FFPE materials. Starting with 40 cases, intact RNA could be isolated from 6, and of these the EWSR1-FLI1 fusion was detected in… (full text at CIViC) PMID 9741544 · Park et al., 1998 · Open in CIViC | civic |
| Elimusertib | Ewing Sarcoma | Predictive | D | Supports Sensitivity Response | 2 | submitted | EID12541In preclinical models of FET fusion–positive cancers, suppression of ATM signaling by the EWSR1-FLI1 oncoprotein created dependence on ATR-mediated repair. The ATR inhibitor elimusertib showed potent … (full text at CIViC) PMID 37205599 · Menon et al., 2025 · Open in CIViC | civic |
| HCI-2509 | Ewing Sarcoma | Predictive | D | Supports Sensitivity Response | 2 | accepted | EID12516Preclinical studies demonstrated that the LSD1 inhibitor HCI-2509 reduced proliferation and induced apoptosis in five EWSR1-FLI1 fusion-positive Ewing sarcoma cell lines (A673, TC32, TC71, SK-N-MC, CH… (full text at CIViC) PMID 24963049 · Sankar et al., 2014 · Open in CIViC | civic |